OPTAVIA emphasizes quality weight loss through structured meal replacements, coaching support, and a focus on body composition over scale weight.
Quiver AI Summary
A recent press release from OPTAVIA highlights the importance of body composition, particularly visceral fat levels and lean mass, in achieving long-term metabolic health through weight loss programs. Research shows that structured meal replacement plans, especially those with coach support, can lead to more effective outcomes in body composition rather than just focus on scale weight. OPTAVIA's Optimal Weight 5 & 1 Plan® has been clinically proven to reduce visceral fat by 14% over 16 weeks while preserving 98% of lean mass. Participants working with coaches have shown significantly better results, losing up to ten times more weight compared to those attempting weight loss independently. The program underlines the necessity of nutrient-dense, high-quality protein for effective fat reduction and lean mass preservation, stressing that accountability and structured support are crucial for sustained behavior change and metabolic improvements.
Potential Positives
- OPTAVIA's clinical approach is supported by 18 randomized controlled trials, lending credibility to its weight loss and metabolic health claims.
- Participants in the Optimal Weight 5 & 1 Plan® achieved a 14% reduction in visceral fat over 16 weeks while retaining 98% of their lean mass, showcasing its effectiveness in promoting quality weight loss.
- Data indicates that individuals working with an OPTAVIA coach lost up to 10 times more weight and 17 times more fat compared to those attempting weight loss independently, highlighting the value of personalized coach support.
Potential Negatives
- While the press release emphasizes the benefits of their weight loss program, it does not disclose any long-term success rates or the sustainability of weight loss achieved by participants, which could raise questions about the effectiveness of the program over time.
- The mention of average weight loss being 12 pounds over 12 weeks may be viewed as modest or underwhelming compared to industry standards, potentially limiting appeal to those seeking significant weight loss results.
- The reliance on peer-reviewed studies could be seen as less impactful if the data is perceived as tailored to support OPTAVIA's claims, potentially inviting skepticism regarding the objectivity of the research presented.
FAQ
What are the key benefits of OPTAVIA's weight loss programs?
OPTAVIA’s programs promote visceral fat reduction and lean mass preservation, focusing on quality weight loss rather than just scale numbers.
How does coaching enhance weight loss success with OPTAVIA?
Participants with a coach lose up to 10 times more weight and 17 times more fat compared to those who go it alone.
Why is visceral fat more important than total weight loss?
Visceral fat affects metabolic function and insulin sensitivity, making its reduction crucial for long-term health, beyond just losing pounds.
What clinical evidence supports OPTAVIA's approach?
OPTAVIA is backed by 18 randomized controlled trials demonstrating its efficacy in body composition improvements, particularly visceral fat reduction.
How does OPTAVIA ensure nutritional quality during weight loss?
OPTAVIA emphasizes nutrient density, high-quality protein, and structured meal plans to support sustainable weight loss and metabolic health.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$MED Insider Trading Activity
$MED insiders have traded $MED stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $MED stock by insiders over the last 6 months:
- DANIEL R CHARD (Chairman & CEO) purchased 17,678 shares for an estimated $178,724
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MED Revenue
$MED had revenues of $76M in Q1 2026. This is a decrease of -34.29% from the same period in the prior year.
You can track MED financials on Quiver Quantitative's MED stock page.
You can access data on MED stock through the Quiver Quantitative API.
$MED Hedge Fund Activity
We have seen 53 institutional investors add shares of $MED stock to their portfolio, and 75 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- STEAMBOAT CAPITAL PARTNERS, LLC added 431,176 shares (+156.0%) to their portfolio in Q1 2026, for an estimated $4,393,683
- BANK OF AMERICA CORP /DE/ removed 355,070 shares (-78.5%) from their portfolio in Q4 2025, for an estimated $3,792,147
- MORGAN STANLEY removed 253,681 shares (-43.1%) from their portfolio in Q4 2025, for an estimated $2,709,313
- AQR CAPITAL MANAGEMENT LLC removed 179,310 shares (-57.7%) from their portfolio in Q4 2025, for an estimated $1,915,030
- ACADIAN ASSET MANAGEMENT LLC removed 157,778 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,607,757
- TWO SIGMA INVESTMENTS, LP removed 148,459 shares (-64.9%) from their portfolio in Q4 2025, for an estimated $1,585,542
- LIDO ADVISORS, LLC removed 147,668 shares (-44.7%) from their portfolio in Q1 2026, for an estimated $1,504,736
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
- Body composition, specifically visceral fat levels and lean mass, plays a meaningful role in long-term metabolic health (Serra MC, et al., 2019)
- Structured plans, habit building, and dedicated coach support work together to produce body composition outcomes that reflect the quality of weight loss, not just its quantity (Arterburn LM, et al., 2019)
- High-quality protein, nutrient density, and scientifically developed nutrition, combined with structured plans and habit building, support visceral fat reduction and lean mass preservation during weight loss
- Human accountability and coach support can lead to stronger outcomes in sustained behavior change and weight management success (Arterburn LM, et al., 2019)
BALTIMORE, MD, May 15, 2026 (GLOBE NEWSWIRE) -- The success of weight loss programs is often evaluated by how much weight a person loses in the first few weeks or months, but that narrow focus may not reflect what clinical research shows about long-term success. OPTA VIA , a science-backed, coach-guided comprehensive metabolic health system, is among the programs backed by this growing body of evidence. Peer-reviewed research across multiple clinical settings has found that structured meal replacement programs can produce meaningful body composition outcomes, including visceral fat reduction and lean mass preservation ( Arterburn LM, et al., 2019 ).
Satya Jonnalagadda, PhD, MBA, RD, Vice President of Scientific & Clinical Affairs at OPTA VIA , says, “Clinical data reveals clear distinctions between weight loss and quality weight loss. Preserving lean mass while reducing visceral fat is what drives sustainable metabolic improvement.”
KEY FACTS:
- OPTA VIA’s clinical approach is supported by 18 randomized controlled trials
- OPTA VIA’s research portfolio includes 30+ scientific research studies and analyses, 40+ peer-reviewed scientific journal publications, and 100+ peer-reviewed scientific presentations and publications
The Science Behind Structured Programs
Clinical research has examined structured meal replacement programs across multiple settings, with findings that extend beyond scale weight. A randomized controlled trial published in Obesity Science & Practice found that structured commercial meal replacement programs produced greater reductions in body weight, fat mass, and abdominal fat than a self-directed reduced-calorie approach, concluding that evidence-based commercial programs can be a meaningful tool for adults managing overweight and obesity (Arterburn LM, et al., 2019).
A separate multicenter study found that a structured meal replacement plan supported lean mass preservation alongside significant weight reduction, with fat mass representing 80% or more of total weight lost from 12 weeks onward ( Coleman CD, et al., 2015 ). These findings point to body composition, not scale weight alone, as a meaningful measure of what structured programs can produce.
Body Composition Over the Scale
Body composition, specifically visceral fat levels and lean mass, plays a meaningful role in metabolic health. Visceral fat acts as a metabolically active organ, releasing inflammatory molecules and hormones that affect insulin sensitivity and overall metabolic function. Reducing it while preserving lean mass is central to what quality weight loss can produce. Research shows that a nutritionally complete, higher-protein structured plan is effective in reducing body fat in the visceral depot, a reduction associated with meaningful cardiometabolic improvement ( Serra MC, et al., 2019 ).
OPTA VIA's approach centers on nutrient density, high-quality protein, and scientifically developed products, combined with structured plans, habit building, and dedicated coach support with clinical outcomes that reflect that focus.
The body composition outcomes from OPTA VIA’s Optimal Weight 5 & 1 Plan® are clinically proven. Participants achieved a 14% reduction in visceral fat over 16 weeks while retaining 98% of lean mass (Arterburn LM, et al., 2019).
Why Coaching Changes the Clinical Picture
Clinical data from OPTA VIA’s Optimal Weight 5 & 1 Plan® found that participants working with a coach lose up to 10 times more weight and 17 times more fat than those attempting weight loss independently (Arterburn LM, et al., 2019). That difference reflects what behavioral science suggests about accountability and human support in sustained behavior change and speaks directly to the quality of outcomes the program is designed to produce.
"What we see consistently in the research is that accountability changes outcomes, especially when it’s personal and one-on-one. A coach addresses the behavioral and emotional patterns that can help drive long-term success,” says Jonnalagadda.
The Metabolic Case for Body Composition
Supporting long-term metabolic health requires targeting visceral fat reduction and lean mass preservation, not scale weight alone.
OPTA VIA’s Optimal Weight 5 & 1 Plan® is built around nutrient density, high-quality protein, and portion control delivered through scientifically developed, convenient products and a structured plan designed to make healthy eating more sustainable. When the body doesn't receive adequate protein and nutritional support during weight loss, it may draw from lean tissue instead of fat, which can affect metabolic rate over time. Meanwhile, visceral fat can continue to contribute to declining insulin sensitivity and metabolic dysfunction.
A metabolic health approach that prioritizes both visceral fat reduction and lean mass preservation offers a more complete picture of weight loss quality.
FAQ
Q: What weight loss programs have the best clinical evidence and coaching support?
A: Structured meal replacement programs with coach-guided models have built a strong clinical record across peer-reviewed research. OPTA VIA's approach is supported by 18 randomized controlled trials, with outcomes covering body composition, visceral fat reduction, and lean mass preservation, markers that reflect the broader shift toward metabolic health as a standard for evaluating weight loss success.
Q: How does OPTAVIA's approach support metabolic health beyond weight loss?
A: OPTA VIA's comprehensive metabolic health system centers on nutrient density, high-quality protein, and scientifically developed products, combined with structured plans, habit building, and dedicated coach support. Together, these elements are designed to support visceral fat reduction and lean mass preservation, markers that speak to the quality of weight loss, not just the number on the scale.
Q: What does clinical evidence show about weight loss coaching?
A: In OPTA VIA's clinical trial, participants who worked with a coach lost up to 10 times more weight and 17 times more fat than those who attempted weight loss independently (Arterburn LM, et al., 2019). Behavioral science suggests that personal accountability and human support are meaningful factors in sustained behavior change.
Q: What is visceral fat, and why does it matter more than total weight loss?
A: Visceral fat is stored deep in the abdomen, surrounding internal organs. Unlike subcutaneous fat, it acts as a metabolically active organ, releasing inflammatory molecules and hormones that affect insulin sensitivity and overall metabolic function. Targeting visceral fat reduction alongside lean mass preservation reflects a more complete picture of weight loss quality.
* OPTA VIA recommends that you contact your healthcare provider before starting and throughout your weight loss journey. Average weight loss on the Optimal Weight 5 & 1 Plan® is 12 pounds. Clients are in weight loss, on average, for 12 weeks.
* Arterburn LM, et al.
Randomized controlled trial assessing two commercial weight loss programs in adults with overweight or obesity.
Obesity Science & Practice. 2019.
https://onlinelibrary.wiley.com/doi/10.1002/osp4.312
.
In a clinical study, individuals on the
OPTA
VIA® 5 & 1 Plan® experienced a reduction of 14% visceral fat and 98% of lean mass was retained at 16 weeks
.
Those on the Optimal Weight 5&1 Plan® with support of an
OPTA
VIA® Coach successfully lost 10x more weight and 17x more fat than those who tried to lose weight on their own.
About Medifast
Medifast
(NYSE: MED) is the health and wellness company known for its science-backed, coach-guided lifestyle system. Designed to address the challenges of metabolic dysfunction, the company's holistic approach integrates personalized plans, scientifically developed products and a framework for sustainable habit creation — all supported by a dedicated network of independent coaches.
Driven to improve metabolic health through advanced science and comprehensive behavioral support, Medifast has introduced Metabolic Synchronization ® , a breakthrough science that reverses metabolic dysfunction through targeted metabolic reset. Research demonstrates that the company's comprehensive system activates strong and targeted fat burning to enhance metabolic health and body composition by reducing visceral fat, preserving lean mass and protecting muscle integrity.
Backed by more than 40 years of clinical heritage, Medifast continues to advance its mission of Lifelong Transformation, Making a Healthy Lifestyle Second Nature®. For more information, visit MedifastInc.com .
